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Delay discounting describes the devaluation of a reinforcer 
as function of increasing delay to its receipt (Odum, 2011). Delay 
discounting has substantial relevance for understanding behavioral 
processes associated with a wide range of problematic behaviors, 
including substance use disorders (SUDs) (for reviews see Bickel, 
Koffarnus, Moody, & Wilson, 2014; Bickel & Marsch, 2001; 
Reynolds, 2006). Greater delay discounting is associated with 
earlier drug use onset (Audrain-McGovern et al., 2009; Ayduk et 
al., 2000), greater addiction severity (Cheng, Lu, Han, Gonzalez-
Vallejo, & Sui, 2012; MacKillop et al., 2010; Ohmura, Takahashi, 
& Kitamura, 2005; Reynolds, 2004; Rezvanfard, Ekhtiari, Mokri, 
Djavid, & Kaviani, 2010), and lower rates of abstinence both in 
laboratory models (Dallery & Raiff, 2007; Mueller et al., 2009) 
and clinical trials (MacKillop & Kahler, 2009; Sheffer et al., 2012; 
Stanger et al., 2012; Yoon et al., 2007). Also, greater discounting 
has been consistently observed among those with SUDs compared 
to matched controls across a wide variety of drugs of abuse (Baker, 
Johnson, & Bickel, 2003; Coffey, Gudleski, Saladin, & Brady, 
2003; Dom, D’Haene, Hulstijn, & Sabbe, 2006; García-Rodríguez, 
Secades-Villa, Weidberg, & Yoon, 2013; Heil, Johnson, Higgins, & 
Bickel, 2006; Hoffman et al., 2006; Kirby & Petry, 2004; Odum, 
Madden, & Bickel, 2002; Petry, 2001). 
Some correlational (Baker, et al., 2003; Takahashi, Furukawa, 
Miyakawa, Maesato, & Higuchi, 2007) and clinical studies (Black 
& Rosen, 2011) have observed that delay discounting is relatively 
stable over time among those with SUDs. Nonetheless, there is 
increasing evidence suggesting that delay discounting may change 
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Abstract
Background: Increasing evidence suggests that delay discounting may 
change following effective interventions. Nonetheless, previous studies 
that assessed the effect of contingency management (CM) on delay 
discounting are scarce, and their results are mixed. The current study 
assessed whether CM in conjunction with a cognitive-behavioral treatment 
(CBT) for smoking cessation was associated with changes in delay 
discounting at end-of-treatment and at 6-month follow-up compared to 
CBT alone. Method: One hundred and sixteen treatment-seeking smokers 
were randomly assigned either to CM + CBT (n = 69) or to CBT alone (n 
= 47). Participants completed delay discounting assessments at the intake, 
at end-of-treatment, and at 6-month follow-up. We evaluated CM’s effect 
on discounting with parametric and nonparametric methods. Results: 
Between-group analyses showed that none of the interventions changed 
delay discounting from intake to end-of-treatment or to 6-month follow-
up. Nonetheless, some within-group analyses showed that the CM + CBT 
condition evidenced some degree of reduction. Conclusions: The current 
results suggest that CM intervention is not robustly associated with delay 
discounting changes. Future studies should address treatments that may 
potentially change delay discounting.
Keywords: Delay discounting, smoking, contingency management, 
cognitive-behavioral treatment.
Resumen
Efectos del manejo de contingencias sobre el descuento por demora en 
pacientes que reciben tratamiento para dejar de fumar. Antecedentes: la 
evidencia sugiere que el descuento por demora puede cambiar tras recibir 
intervenciones efi caces. No obstante, estudios previos que evaluaron el 
efecto del manejo de contingencias (MC) sobre el descuento por demora 
son escasos y presentan resultados mixtos. Se evaluó si el MC combinado 
con tratamiento cognitivo-conductual (TCC) para dejar de fumar se asoció 
con cambios en el descuento por demora al fi nal del tratamiento y a los seis 
de seguimiento comparado con TCC. Método: Ciento dieciséis fumadores 
fueron asignados aleatoriamente a MC+TCC (n = 69) o a TCC solo (n 
= 47). Completaron la tarea de descuento por demora en la línea base, 
al fi nal del tratamiento y a los seis meses de seguimiento. Evaluamos el 
efecto del MC en el descuento por demora con métodos paramétricos y 
no paramétricos. Resultados: Los análisis entre-grupos mostraron que 
ninguno de los tratamientos modifi có el descuento por demora al fi nal 
del tratamiento y a los seis meses de seguimiento. No obstante, algunos 
análisis intra-grupos mostraron que la condición de MC + TCC evidenció 
cierta reducción. Conclusiones: una intervención de MC no se asocia 
robustamente con cambios en el descuento por demora. Futuros estudios 
han de abordar qué tratamientos pueden modifi carlo.
Palabras clave: descuento por demora, tabaco, manejo de contingencias, 
tratamiento cognitivo-conductual.
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under different pharmacological or environmental conditions 
(Dallery & Raiff, 2007; Koffarnus, Jarmolowicz, Mueller, & 
Bickel, 2013). For instance, increases in delay discounting 
have been observed following acute administration of alcohol 
among social drinkers (Reynolds, Richards, & de Wit, 2006). 
Likewise, increased discounting has been observed following 
acute deprivation of their drug of choice among cigarette smokers 
(Ashare & Hawk, 2012; Field, Santarcangelo, Sumnall, Goudie, 
& Cole, 2006; Mitchell, 2004; Yi & Landes, 2012) and opioid-
dependent individuals (Giordano et al., 2002). Discounting rates 
also increased among pathological gamblers in gambling contexts 
(Dixon & Holton, 2009; Dixon, Jacobs, & Sanders, 2006). 
Relatively few studies have examined the effect of clinical 
interventions on delay discounting among individuals with SUDs. 
Among those completed, decreased delay discounting has been 
observed following a working memory training procedure for 
stimulant-dependent individuals (Bickel, Yi, Landes, Hill, & 
Baxter, 2011) and a money-management intervention for cocaine- 
and/or alcohol-dependent individuals (Black & Rosen, 2011). The 
effects of contingency management (CM) on delay discounting 
have been mixed. Two studies showed that CM led to signifi cant 
reductions in delay discounting rates among smokers (Yi et al., 
2008) and opioid-dependent individuals receiving multimodal 
treatments of which CM was a part of each (Landes, Christensen, 
& Bickel, 2012), whereas no changes in delay discounting were 
observed among marijuana-dependent individuals receiving CM 
treatment (Peters, Petry, LaPaglia, Reynolds, & Carroll, 2013).
Taken together, these results suggest that delay discounting 
may change in response to effective CM treatment, but the limited 
number of studies makes further research necessary to confi rm 
these fi ndings (Bickel, et al., 2014). Also, whether changes in 
delay discounting persisted following termination of treatment 
is unknown, as previous studies only report end-of-treatment 
results. 
The present study addresses this gap in the literature investigating 
whether CM in conjunction with cognitive-behavioral treatment 
(CBT) for smoking cessation was associated with changes in 
delay discounting at end-of-treatment and at 6-month follow-up. 
In this sense, previous research has showed that adding CM to 
CBT is effective for treating nicotine dependence. For instance, 
Secades-Villa, García-Rodríguez, López-Núñez, Alonso-Pérez, & 
Fernández-Hermida (2014) found that 95.3% of the smokers who 
received CM + CBT achieved abstinence after a 6-week treatment 
for smoking cessation, while only 59.2% of smokers who received 
CBT alone were abstinent at the end-of-treatment. Given that CM 
+ CBT was more effective than CBT alone in order to promote 
abstinence, it is possible that this protocol could also lead to 
greater delay discounting changes. In the present study, potential 
delay discounting changes from intake to both end-of-treatment 
and 6-month follow-up were compared between participants who 
received CBT alone and those who received CM + CBT. 
Method
 
Participants
Participants were 123 individuals seeking treatment for cigarette 
smoking at the Addictive Behaviors Clinic of the University of 
Oviedo (Spain). Inclusion criteria were as follows: being over 
18 years old, smoking 10 or more cigarettes per day for the last 
year and meeting criteria for nicotine dependence according to 
the Diagnostic and Statistical Manual of Mental Disorders (4th 
ed., text rev.; DSM–IV–TR) (American Psychiatric Association, 
2000). Participants were excluded if they were diagnosed with 
a current psychiatric disorder (including substance use disorder 
besides nicotine dependence) or if they were receiving any other 
smoking cessation treatment. This study was approved by the 
Institutional Review Board of the University of Oviedo, and 
informed consent was obtained from all participants prior to 
study initiation. Seven participants (3 assigned to the CM + CBT 
condition and 4 assigned to the CBT condition) were excluded 
because they presented nonsystematic delay discounting data 
(Johnson & Bickel, 2008). 
Eligible participants were randomly assigned to either the CM 
+ CBT condition (n = 69) or CBT condition (n = 47). Table 1 shows 
the counts of participants who supplied delay discounting data at 
all the assessments (intake, end-of-treatment and 6-month follow-
up) as well as those who missed one or more of these assessments. 
There were no signifi cant differences between conditions in any 
sociodemographic and smoking-related variables (Table 2) or 
delay discounting rates at the intake (Table 3). 
Instruments and variables
Sociodemographic (age, gender and marital status) and 
smoking-related [cigarettes per day, years of regular smoking, 
carbon monoxide (CO) and cotinine] characteristics were assessed 
Table 1
Counts of participants who supplied delay discounting data for each group and 
assessment
Intake only
Intake + end-
of- treatment
Intake + 
6-month 
follow-up
All three as-
sessments
Total
CBT 1 6 1 39 47
CBT+CM 0 4 0 65 69
Total 1a 10 1 104 116
Note: CBT = cognitive-behavioral treatment; CM = contingency management.
 a = Data from this participant is included in analyses that relate to inference on intake-
only measures
Table 2
Participants’ characteristics at intake
CBT 
(n = 47)
CM + CBT
(n = 69)
Statistic 
value
p value
Age (years)a 47.53 ± 11.27 43.36 ± 13.78 1.7861 .077
Gender (% women)  55.3 66.7 1.0852 .298
Marital status (% married) 55.3 42 2.4083 .492
Cigarettes per daya 23.66 ± 9.41 20.52 ± 8.52 1.8671 .064
Years of regular smokinga 27.48 ± 10.95 25.18 ± 13.40 0.9671 .336
CO (ppm)a 16 ± 6.86 14.51 ± 5.99 1.2421 .217 
Cotinine (ng/ml)a 2,267.8 ± 1,110 2,424 ± 1,272 -0.6191 .538
Note: CBT = cognitive-behavioral treatment;  CM = contingency management; CO = 
carbon monoxide;  ppm = parts per million; ng/ml = nanogram/milliliter.
a = Means ± SD; Statistic used: 1 Student’s t; 2 Yates’ Continuity Correction; 3 Chi-squared
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during the intake session, which lasted about 1 and a half hours. 
The Structured Clinical Interview (SCID-I) of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV-TR) (American 
Psychiatric Association, 2000) was used to assess nicotine 
dependence.
Smoking status was assessed at intake, end-of-treatment and 
6-month follow-up. Participants provided a breath CO using a 
Micro Smokerlyzer (Bedfont Scientifi c Ltd., Rochester, UK). A 
BS-120 chemistry analyzer (Shenzhen Mindray Bio-medical 
Electronics, Co., Ltd., Shenzhen, P. R, China) was also used to 
assess urine cotinine levels. Self-reported smoking abstinence at 
the end-of-treatment and at 6-month follow-up was validated by 
presenting a breath CO level ≤ 4 ppm (Perkins, Karelitz, & Jao, 
2013) and a cotinine test < 80 ng/ml. Agreement between the three 
measures was required to be categorized as abstinent. Participants 
were considered as smokers when they missed an assessment.
The delay discounting task was presented to participants at 
intake, end-of-treatment and 6-month follow-up via a laptop running 
the Windows Operating system. The task took approximately 
10 minutes to complete for each participant. Participants were 
instructed how to interact with the delay discounting program 
and informed that they would not receive any of the monetary 
amounts presented, but they had to respond as if the choices were 
real. Participants were presented with a choice between €1,000 
after a fi xed delay versus various amounts of money available 
immediately using an adjusting-amounts procedure (Holt, Green, 
& Myerson, 2012). The delays values used were 1 day, 1 week, 1 
month, 6 months, 1 year, 5 years and 25 years. The delays were 
presented in an ascending order for all the participants. The value 
of the immediate monetary option ranged from €5 to €1,000 in €5 
increments and was adjusted via a titrating procedure that honed 
in on the indifference point based on the participants’ responses. 
The titration procedure took the lower and upper limit of possible 
values (initial €0 and €1,000) and divided this total range by 2, 3 
or 4 to obtain an interval value. The value of the immediate option 
was one interval value above or below the upper and lower limits. 
If the immediate value was outside €0 and €1,000, another value 
was randomly chosen. New lower and upper limits were chosen 
based on the participant’s response, adjusting the total range, and 
this titration procedure was repeated for each of the seven delays. 
Note that based on the possible values presented, the total values 
could occasionally increase if they chose an option outside of 
the total range. Once the total range was at or less than €40, the 
average of the upper and lower limits was taken as the indifference 
point, and the next delay was presented.
Treatment conditions
CBT
CBT consisted of a 6-week intervention described in previous 
studies (Becoña & Vázquez, 1997; Secades-Villa, Alonso-Perez, 
García-Rodríguez, & Fernández-Hermida, 2009; Secades-Villa, 
et al., 2014). CBT was implemented in group-based sessions 
of six patients. Each weekly session lasted about 1 hour. The 
components of the CBT were highly structured and included: 
information about tobacco, a behavioral contract, self-monitoring 
and graphical representation of cigarette smoking, nicotine fading, 
stimulus control, strategies for controlling nicotine withdrawal 
symptoms, physiological feedback consumption, training 
in alternative behaviors, social reinforcement of objectives 
completion and abstinence, and relapse prevention strategies. CO 
and cotinine specimens were collected twice a week. One of the 
measures coincided with the weekly CBT session and the other 
was scheduled midweek between sessions.
CM + CBT
 
The CM + CBT condition was similar to the CBT condition, 
but with the addition of CM. Participants were randomly assigned 
to two types of CM procedures: CM for smoking abstinence or 
CM for shaping abstinence. The CM for smoking abstinence 
included a voucher program in which nicotine abstinence was 
reinforced on an escalating schedule of reinforcement with a reset 
contingency. Points were earned for specimens testing negative 
for cotinine (< 80 ng/ml) from the fi fth session forward (once 
the patients were required to be completely abstinent) (Secades-
Villa, et al., 2014). The CM for shaping abstinence included a 
voucher program in which progressive reductions in cotinine 
(with abstinence also as fi nal target) were reinforced according 
to an individualized percentile schedule. Points were earned for 
specimens that met the reduction criteria from the fi rst session 
forward (Lamb, Kirby, Morral, Galbicka, & Iguchi, 2010; López-
Núñez, Loredo-Martínez, Weidberg, Pericot-Valverde, Secades-
Villa, 2015). Points were worth the equivalent to 1€ each. The 
maximum amount that patients could earn in both procedures was 
300€. Points were exchangeable for vouchers with a variety of 
uses, including leisure activities, cinema, theater, museums, sport 
Table 3
Summary statistics of AUC and ln(k) for each treatment condition and 
assessment period. Between-groups comparisons for each assessment period are 
also provided
Treatment
condition
Assessment
period
AUC ln(k)
N Mean Std Dev. Mean Std Dev.
CBT Intakea 47 0.18 0.15 -4.29 2.78
Intake 46 0.19 0.15 -4.34 2.79
End-of-
treatment
45 0.19 0.19 -4.32 2.79
6-month 
follow-up
40 0.19 0.15 -4.29 2.93
CM+CBT Intake 69 0.23 0.18 -5.01 2.68
End-of-
treatment
69 0.28 0.22 -5.45 2.72
6-month 
follow-up
65 0.26 0.20 -5.68 2.15
CBT vs. 
CM+CBT
Assessment
period
AUC ln(k)
t
(gl)
p t
(gl)
p
Intakea -1.303(114) .195 1.399(114) .165
Intake 1.198(113) .234 1.293(113) .199
End-of-treatment -2.320(112) .022 2.160(112) .033
6-month follow-up -1.994(102) .049 2.800(102) .006
Note: CBT = cognitive-behavioral treatment; CM = contingency management; AUC = 
Area Under the Curve; ln(k) = natural logarithm of k value
a Data including a participant who complete intake assessment only
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events, gyms, adventure sports, meals in restaurants, training, 
purchases in department stores, and spa and beauty services 
(Secades-Villa, et al., 2014). In both procedures, participants were 
encouraged by therapists to consider spending their vouchers 
on goods and services that promote a healthier lifestyle. As no 
signifi cant differences in abstinence rates between the two CM 
conditions were observed (López-Núñez, et al., 2015), data from 
the two conditions were combined for the current study. 
Data analysis
We summarized the indifference points from each discounting 
task in two ways: area under the curve – AUC; and the natural 
logarithm of the hyperbolic k parameter – ln(k). Myerson, Green 
& Warusawitharana (2001) proposed AUC as an atheoretical 
discounting measure that avoids assumptions of any particular 
discounting model (Odum, 2011; Odum & Rainaud, 2003). AUC 
takes values from 1 (no discounting) to 0 (maximum discounting). 
For ln(k), we fi tted the indifference points with a nonlinear 
regression model having the form of Mazur’s (1987) hyperbolic 
equation
E(Y)= 1/(1+exp[ln(k)]D), (1)
where E(Y) is the expected indifference point at delay D, given the 
subject discounts at rate k = exp[ln(k)]. We estimated ln(k) since 
the distribution of k across subjects tends to be approximately log-
normal in distribution.
To measure within-individual change in discounting between 
intake and either end-of-treatment or 6-month follow-up, we took 
the difference. For example, AUC change at end-of-treatment was 
defi ned as intake AUC minus end-of-treatment AUC, and ln(k) 
change at 6-month follow-up as 6-month follow-up ln(k) minus 
intake ln(k). Computed as such, a negative difference indicates a 
decrease from intake discounting in both AUC and ln(k). We focus 
our analyses on the differences from intake discounting, and refer 
to these as d
AUC
 and d
lnk
. 
We analyzed both the d
AUC
 and d
lnk
 data in an analysis of 
variance (ANOVA) context having CM as a between-group 
factor, and both assessment period and CM × assessment 
period as within-group factors. Using the Bayesian information 
criterion, we chose a compound symmetric covariance structure 
(equivalent to a fi rst-order autoregressive structure) over an 
unstructured covariance. Kenward-Roger method (Arnau, 
Bendayan, Blanca, & Bono, 2014; Littell, Milliken, Stroup, 
Wolfi nger, & Schabenberger, 2006) was used in order to estimate 
the error degrees of freedom.
Although a population may experience a mean signifi cant 
decrease on delay discounting over time, individuals may deviate 
from this pattern by either not shifting at all, or shifting in the 
opposite direction. In order to assess whether each individual 
showed a statistically signifi cant change in his or her delay 
discounting from one assessment period to another, we used the 
sign rank test described in Hadden (2012).  This test uses the 
differences of indifference points paired on the delay from which 
they came while assuming no mathematical model of discounting. 
We tested whether each individual statistically changed from 
intake to both end-of-treatment and 6-month follow-up. We then 
used χ² tests to compare the CM groups for differences in the 
proportions of those statistically changing.   
Primary analyses were conducted in SAS/STAT software, 
Version 9.3, SAS System for Windows (SAS Institue Inc., Cary, 
NC, USA), with linear mixed models fi tted in the MIXED 
procedure. Confi dence level was 95%.
Results
Delay discounting changes and treatment conditions
For each CM group and assessment period, Table 3 provides 
summary statistics of the delay discounting measures, and Table 
4 the estimated change from intake discounting (d). Averaging 
over end-of-treatment and 6-month follow-up, change from 
intake discounting (d) did not signifi cantly differ between the 
two treatment conditions, F
AUC
(1, 112) = 1.25, p = .267; F
lnk
(1, 111) 
= 1.19, p = .278; nor was there evidence of a CM × assessment 
period interaction, F
AUC
(1, 105) = 1.04, p = .310; F
lnk
(1,103) = 0.03, 
p = .874. However, the CM + CBT group evidenced decreased 
discounting at both end-of-treatment, t
AUC
(154) = 2.34, 
 
p = .021; 
t
lnk 
(154) = 1.41, p
 
 = .160, and 6-month follow-up, t
AUC
(160) = 1.67, 
p = .097; t
lnk
 (160) = 0.04, p = .032; whereas CBT participants 
did not change their discounting neither at the end-of-treatment, 
Table 4
Estimated mean change from Intake AUC and ln(k) with comparisons of CM groups added
AUC ln(k)
Assessment
period
Treatment
condition
Mean t-statistic Mean t-statistic 
Changea 95% CIa &p-value Changea 95% CIa &p-value
End-of-
treatment
CBT -0.0 (-5.7, +5.6) t
156
=0.00, p=.997 +1.5 (-74.3, +77.4) t
156
=0.04, p=.968
CBT+CM -5.4 (-10.0, -0.8) t
154
=2.34, p=.021 -44.0 (-105.5, +17.5) t
154
=1.41, p=.160
CBT vs. CBT+CM -5.4 (-12.7, +1.9) t
155
=1.47, p=.144 45.6 (-143.2, +52.1) t
155
=0.92, p=.358
6-month CBT -1.8 (-7.7, +4.0) t
168
=0.62, p=.538 -16.1 (-94.7, +62.6) t
169
=0.40, p=.688
follow-up CBT+CM -3.9 (-8.6, +0.7) t
160
=1.67, p=.097 -68.7 (-131.3, -6.0) t
160
=0.04, p=.032
CBT vs. CBT+CM -2.1 (-9.6, +5.4) t
165
=0.56, p=.579 -52.6 (-153.1, +47.9) t
166
=1.03, p=.303
Note: CBT = cognitive-behavioral treatment; CM = contingency management; AUC = Area Under the Curve; ln(k) = natural logarithm of k value
a = Actual AUC and ln(k) values have been multiplied by 100
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t
AUC
(156) = 0.00, 
 
p = .997; t
lnk 
(156) = 0.04, p
 
 = .968, or at 6-month 
follow-up, t
AUC
(168) = 0.62, 
 
p = .538; t
lnk 
(169) = 0.40, p
 
 = .688. 
Averaged the change over the two time periods, change from 
intake discounting was signifi cantly decreased in the CM + CBT 
group, t
AUC
(110) = 2.21, p = .029; t
lnk
(108) = -1.99, p = .049, but 
statistically unchanged in the CBT group, t
AUC
(114) = 0.35, p = 
.726; t
lnk
(112) = -0.21, p = .836.    
Distributions of individually-based changes in delay discounting 
Figures 1 and 2 show the proportions of participants who 
statistically decreased, experienced no signifi cant change, or 
signifi cantly increased their delay discounting rates as a function 
of treatment condition at the end-of-treatment and at 6-month 
follow-up, respectively. There were no signifi cant differences 
between the two treatment conditions in these proportions either 
at end-of-treatment, χ2
(2)  
= 0.090, p =.956, or at 6-month follow-up, 
χ2
(2)  
= 1.053, p =.591.
The sign rank test showed that the rank correlation between 
these two assessment periods were 0.61 (p<.001, n = 39) for the 
CBT group and 0.62 (p<.001, n = 65) for the CM + CBT group. 
Results using ln(k) change measures were similar: correlations 
were 0.53 and 0.62 (both p<.001) for CBT and CM + CBT groups, 
respectively. 
Abstinence outcomes
 
Abstinence rates are described in detail in a previous delay 
discounting study (Weidberg, Landes, García-Rodríguez, Yoon, 
& Secades-Villa, 2015). Effectiveness results showed that 
participants in the CM + CBT condition achieved higher rates of 
abstinence than those in the CBT condition at the end-of-treatment. 
Nonetheless, abstinence rates did not signifi cantly differ between 
conditions at 6-month follow-up.
Discussion
The main purpose of the present study was to assess whether 
CM added to a CBT intervention for smoking cessation was 
associated with changes in delay discounting at end-of-treatment 
and at 6-month follow-up. There are three noteworthy outcomes of 
the current study: (a) between-group analyses showed no statistical 
differences among treatment conditions; (b) within-group analyses 
showed that participants in the CM + CBT condition evidenced 
some degree of discounting decrease that depended on the measure 
of discounting used; participants in the CBT condition failed to 
show no statistical change across time; and (c) distributions of 
individually-based changes in delay discounting were similar in 
both treatment conditions.
The vast majority of the analyses conducted showed that neither 
the CBT nor the CM + CBT interventions changed delay discounting 
from intake to both end-of-treatment and 6-month follow-up. Similar 
results were found in a previous work from Peters et al. (2013), who 
showed that marijuana dependents did not change their discounting 
after receiving a 12-week CM treatment, either alone or combined 
with CBT. Nonetheless, this previous study showed that participants 
who received CBT alone increased their discounting from intake 
to end-of-treatment, while in the present study participants who 
received CBT alone did not statistically change their discounting 
across time. It is possible that only specifi c treatments, such as those 
that directly target executive functioning (see Bickel et al., 2011) or 
psychopharmacological approaches that use cognitive enhancers 
(Bickel, Jarmolowicz, Mueller, Koffarnus, & Gatchalian, 2012) are 
effective to reduce delay discounting. Future research should also 
assess which treatments or combination of treatment components 
is most effective in order to reduce impulsive decision making 
(Bickel et al., 2012).
The within-groups  reductions observed in some of the 
discounting measures among the CM + CBT condition may be 
Figure 1. Within-individual change from intake AUC at end-of-treatment 
among the CBT and CM + CBT groups. Circles represent no statistical 
change; triangles statistical increase; inverted triangles statistical 
decrease
Figure 2. Within-individual change from intake AUC at 6-month follow-
up among the CBT and CM + CBT groups. Circles represent no statistical 
change; triangles statistical increase; inverted triangles statistical 
decrease
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primarily attributed to a more pronounced decrease in delay 
discounting at the individual level among participants who showed 
discounting reductions and received CM, compared to those 
participants who evidenced discounting reductions but did not 
received CM. Factors such as immediate access to reinforcers for 
drug abstinence and the opportunity to consider spending vouchers 
on goods and services that promote a healthier lifestyle provided 
by CM (Chivers & Higgins, 2012; Higgins, Silverman, Sigmon, 
& Naito, 2012) may explain the signifi cant decreases in delay 
discounting from intake levels among these specifi c individuals. 
The present study has several limitations that point to future 
research lines. First, delay discounting rates were assessed using 
hypothetical monetary rewards and one may question whether 
the present fi ndings would be similar as for discounting of real 
rewards. Nonetheless, previous research has found comparable 
results when hypothetical and real rewards are used (Baker, et al., 
2003; Johnson & Bickel, 2002; Johnson, Bickel, & Baker, 2007; 
Lagorio & Madden, 2005; Madden, Begotka, Raiff, & Kastern, 
2003; Madden et al., 2004). Second, there is a lack of statistical 
control of abstinence from smoking in the present study, which 
could affect the results found. Nevertheless, given that abstinence 
rates did not differ between treatment conditions at 6-month 
follow-up, abstinence is not expected to be a variable that could 
impact delay discounting in the present study. Third, this sample 
consisted of a particularly moderate dependent group of smokers. 
Future research should assess whether the present results can be 
applicable to smokers with lower or greater levels of nicotine 
dependence. Future studies should also explore whether the 
current results can be generalized among individuals with other 
SUDs than nicotine dependence. Lastly, further research needs 
to be conducted to determine whether the present results are 
maintained with longer-term follow-ups. 
Despite these limitations, our study shows that CM intervention 
did not appear to be robustly associated with delay discounting 
changes among a sample of treatment seeking adult smokers. Given 
the scarcity of studies that assessed whether any intervention, 
including CM, is related to delay discounting changes, more 
studies will be needed to confi rm the present fi ndings.
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